Pharmacology, Toxicology and Pharmaceutical Science
Lansoprazole
96%
Ranitidine
76%
Pharmacodynamics
76%
Sepsis
76%
Omeprazole
70%
Proton Pump Inhibitor
65%
Pharmacokinetics
62%
2 Propanol
57%
Antibiotic Agent
57%
Antibiotics
54%
Observational Study
51%
Pharmacotherapy
50%
Azithromycin
48%
Ceftriaxone
48%
Stress Ulcer
45%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
38%
Tobramycin
38%
Calcium Sulfate
38%
Rat Model
38%
Quinidine Gluconate
38%
Disease
29%
Tablet
28%
Normal Human
28%
Antibiotic Therapy
24%
Elimination Rate Constant
24%
Antiinfective Agent
24%
Cigarette Smoking
23%
Upper Gastrointestinal Bleeding
23%
Sodium Chloride
22%
Toxic Injury
21%
Piperacillin Plus Tazobactam
21%
Infection
21%
Route of Administration
20%
Ciprofloxacin
19%
Treprostinil
19%
Pulmonary Hypertension
19%
Statin (Protein)
19%
Prostacyclin
19%
Experimental Osteomyelitis
19%
Medication Error
19%
Linezolid
19%
Protein Binding
19%
Creatinine
19%
3 Hydroxyquinidine
19%
Famotidine
19%
Cimetidine
19%
Cefepime
19%
Meropenem
19%
Voriconazole
19%
Vasoactive Agent
19%
Keyphrases
Critically Ill Patients
81%
Critical Illness-related Corticosteroid Insufficiency
76%
Critical Care Medicine
57%
Intensive Care Medicine
57%
European Society
57%
Ranitidine
38%
Lansoprazole
38%
Mononuclear Cells
38%
Omeprazole
38%
Phenytoin
38%
Formulary
38%
Septic Shock
32%
Multispecialty
32%
Intestinal Transplant
28%
Adult Patients
27%
Corticosteroids
23%
Intensive Care Unit
22%
Adult Intensive Care Unit
21%
Proton Pump Inhibitors
21%
Transplant Population
21%
Critical Care
21%
Pediatric Patients
20%
Academic Conflict
19%
Extended-spectrum-lactamase
19%
Aspiration Syndrome
19%
Pulmonary Arterial Hypertension
19%
Treprostinil
19%
Epoprostenol
19%
Surgical Debridement
19%
Steroid Medication
19%
Tobramycin
19%
Calcium Sulfate
19%
Pharmacodynamic Response
19%
Experimental Osteomyelitis
19%
Tetanus
19%
Type 2 Diabetic Patients
19%
Sustained Low-efficiency Dialysis
19%
5% Dextrose Injection
19%
Chronic Hypertension
19%
Intrapulmonary Pharmacokinetics
19%
Pharmacodynamics
19%
Safe Administration
19%
Iron Dextran
19%
Mobility Bundles
19%
Monitoring Management
19%
Suspension Stability
19%
Green Plastics
19%
Klebsiella Pneumoniae (K. pneumoniae)
19%
Critical Care Research
19%
Pharmacotherapy Trials
19%
Medicine and Dentistry
Intensive Care Medicine
100%
Critical Illness
96%
Intensive Care
71%
Intensive Care Unit
64%
Hydrocortisone
60%
Drug Therapy
49%
Lipid Pneumonia
38%
Delirium
38%
Proton-Pump Inhibitor
38%
Shock (Circulatory)
24%
Penicillinase
23%
Upper Gastrointestinal Bleeding
23%
Observational Study
21%
Pulmonary Aspiration
19%
Tetanus
19%
Hospital Mortality
19%
Iron Dextran
19%
Vasoactive Agent
19%
Health Care Associated Pneumonia
19%
Decision Making
19%
Odds Ratio
19%
Adult Critical Care
19%
Flumazenil
19%
Breathing
19%
Clavulanate Potassium
19%
Gram Negative Sepsis
19%
Immunoglobulin M Antibody
19%
Paraprotein
19%
Predictive Factor
19%
K-Complex
19%
Quinidine Gluconate
19%
Klebsiella pneumoniae
19%
Peptic Ulcer Bleeding
19%
Extended Spectrum Beta Lactamase
19%
Transplantation
19%
Esomeprazole
19%
Rosuvastatin
19%
Antiinfective Agent
17%
Antimicrobial Therapy
16%
Glucocorticoid
16%
Pediatrics Patient
14%
Health Care
12%
Community-Acquired Pneumonia
11%
Sepsis
10%
Septic Shock
10%
Pathophysiology
10%
Acute Respiratory Distress Syndrome
10%
Injury
10%
Endocrinology
10%
Systematic Review
10%